Teladoc Health, Inc. (NYSE:TDOC) is looking for M&A. Jason Gorevic said that ? we continue to be actively looking for opportunities for appropriate and prudent M&A to expand our clinical footprint and the breadth of our clinical services?.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.12 USD | -2.07% | -7.05% | -48.58% |
May. 21 | JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating | MT |
Apr. 29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.29% | 1.93B | |
+114.61% | 4.1B | |
+78.57% | 584M | |
+11.02% | 480M | |
-71.13% | 128M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health Seeks M&A